USD LIBOR news gives market indigestion after Thanksgiving

01 December 2020

Phil LloydManaging Director, Head of Customer Sales Delivery

View bio

John Stevenson-HamiltonLIBOR Client Strategy & Engagement

View bio

Other insights

View more insights

Any still dozing after too much turkey during Thanksgiving were given a jolt yesterday (30 November) with the apparent news that USD LIBOR1 would carry on until 30 June 2023. But is that really what was said?

No. Or at least that’s not the whole story...

ICE2 announced a consultation on ceasing publication of 1w and 2m USD LIBOR after 31 December 2021, and for all other tenors from 30 June 2023. Pause for stunned silence. ...2023?? That’s a year and a half later than current expectations for GBP LIBOR. In You wait for ages... we noted USD’s omission from the previous ICE announcement on GBP, but we weren’t expecting quite such a delay.

BUT all is not quite as it seems. Both the Fed and FCA made accompanying statements to the ICE one, and this is what you really need to focus on. Basically the Fed (+ FDIC & OCC) said they do not expect any new trading in USD LIBOR after 31 December 2021. The Fed was emphatic that they believe “entering into new contracts that use USD LIBOR as a reference rate after December 31, 2021, would create safety and soundness risks and [we] will examine bank practices accordingly”.

The FCA3 welcomed the US measures “limiting new use of US$ LIBOR after end-2021”. And the ARRC4 applauded the “major milestone in transition from USD LIBOR”. So the authorities are very much emphasising the point about no trading LIBOR after December 2021, not the final $ cessation date in June 2023.

So what are the key takeaways?

•     the 2023 date is about managing down ‘tough legacy’ exposure, not extending the life of USD LIBOR

•     this shouldn’t come as a surprise...Randal Quarles in his testimony to the US Senate Banking Committee in early November said “We need to consider a mechanism that would allow so-called legacy contracts, the great bulk of them, to mature on their existing basis without having to be renegotiated and shifted to a new rate without allowing the continuation of the writing of new contracts.”

•     the measures across GBP & USD are actually quite aligned...same timing for ICE consultations (end Jan 21), same timing to stop referencing LIBOR in new trades (end 2021)...and we think likely same timing for announcement of ‘X’, the fixing of the spread adjustment (Feb-Mar 21)

•     there is no impact on the GBP LIBOR timelines

The point about when ‘X’ will be announced is causing some discussion in the market. We don’t see why the delay on the final cessation of USD LIBOR should mean that the announcement date will be any later than for GBP. The spread can still be snapped early 2021 (the 5 year median lookback), there will just be a longer time until it is triggered in fallbacks.

So it’s still end 2021

The main point we think is most worth calling out is the powerful joint supervisory message that there will be no new LIBOR business from the end of 2021. 

This means that firms need to be ready, banks need to be ready, markets need to think that a Feb next year announcement snap is likely and maybe the June 2023 date is really just focusing on another way of delivering the tough legacy solution.

Yes the US market needs to get going, building liquidity, creating a term rate for the few not the many, the legislative solution needs more pace and more importantly the wider community need to wake up from a heady Thanksgiving to the fact the things are moving faster than their head may have felt ready for. 

1

LIBOR

London Interbank Offered Rate

2

ICE

Intercontinental Exchange, Inc.

3

FCA

Financial Conduct Authority

4

ARRC

Alternative Reference Rates Committee

LIBOR


This article has been prepared for information purposes only, does not constitute an analysis of all potentially material issues and is subject to change at any time without prior notice. NatWest Markets does not undertake to update you of such changes.  It is indicative only and is not binding. Other than as indicated, this article has been prepared on the basis of publicly available information believed to be reliable but no representation, warranty, undertaking or assurance of any kind, express or implied, is made as to the adequacy, accuracy, completeness or reasonableness of the information contained in this article, nor does NatWest Markets accept any obligation to any recipient to update or correct any information contained herein. Views expressed herein are not intended to be and should not be viewed as advice or as a personal recommendation. The views expressed herein may not be objective or independent of the interests of the authors or other NatWest Markets trading desks, who may be active participants in the markets, investments or strategies referred to in this article. NatWest Markets will not act and has not acted as your legal, tax, regulatory, accounting or investment adviser; nor does NatWest Markets owe any fiduciary duties to you in connection with this, and/or any related transaction and no reliance may be placed on NatWest Markets for investment advice or recommendations of any sort. You should make your own independent evaluation of the relevance and adequacy of the information contained in this article and any issues that are of concern to you.

This article does not constitute an offer to buy or sell, or a solicitation of an offer to buy or sell any investment, nor does it constitute an offer to provide any products or services that are capable of acceptance to form a contract. NatWest Markets and each of its respective affiliates accepts no liability whatsoever for any direct, indirect or consequential losses (in contract, tort or otherwise) arising from the use of this material or reliance on the information contained herein. However this shall not restrict, exclude or limit any duty or liability to any person under any applicable laws or regulations of any jurisdiction which may not be lawfully disclaimed.

NatWest Markets Plc. Incorporated and registered in Scotland No. 90312 with limited liability. Registered Office: 36 St Andrew Square, Edinburgh EH2 2YB. Authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and Prudential Regulation Authority. NatWest Markets N.V. is incorporated with limited liability in the Netherlands, authorised and regulated by De Nederlandsche Bank and the Autoriteit Financiële Markten. It has its seat at Amsterdam, the Netherlands, and is registered in the Commercial Register under number 33002587. Registered Office: Claude Debussylaan 94, Amsterdam, the Netherlands. Branch Reg No. in England BR001029. NatWest Markets Plc is, in certain jurisdictions, an authorised agent of NatWest Markets N.V. and NatWest Markets N.V. is, in certain jurisdictions, an authorised agent of NatWest Markets Plc. NatWest Markets Securities Japan Limited [Kanto Financial Bureau (Kin-sho) No. 202] is authorised and regulated by the Japan Financial Services Agency. Securities business in the United States is conducted through NatWest Markets Securities Inc., a FINRA registered broker-dealer (http://www.finra.org), a SIPC member (www.sipc.org) and a wholly owned indirect subsidiary of NatWest Markets Plc.

Copyright 2020 © NatWest Markets Plc. All rights reserved.